Stated preferences for anti-malarial drug characteristics in Zomba, a malaria endemic area of Malawi

Malaria Journal

Table 1 Choice data and participant characteristics

Variables	Rural	Peri-Urban	Urban
N of participants	364	80	64
N of scenarios	2911	640	512
N of scenarios where no drug profile was chosen (%)	129 (4.4)	23 (3.6)	12 (2.3)
Sex (Male)%	63.2	51.6	51.2
No formal education%	25.0	6.2	4.7
No formal occupation%	8.2	8.7	9.4
Radio at home%	69.5	88.8	98.4
Per capita monthly expenditure -$¹	19.47	57.51	286.73
Household poor -%²	87.0	91.6	41.2
‘Preferred anti-malarial’:
SP	43.9	57.5	45.3
Quinine	5.2	13.7	20.3
Halofantrine/Mefloquine	0	0	9.4
Chloroquine	1.4	2.5	6.2
Antipyretic/painkiller	4.9	5	1.6
Antibiotic	7.4	3.7	0
No preferred anti-malarial	36.8	17.5	15.6

One respondent (0.27%) residing in a rural area stated having a preferred anti-malarial but did not provide name.
¹Exchange rate $1= Malawian Kwacha108.8374; average for February 2004; source: IMF (2004). Reflated to 2006 prices using CPI (All items – US Bureau of Labor Statistics; http://www.bls.gov/cpi/data.htm accessed 31 July 2007). n=28 cases had missing information on monthly expenditure; rural areas n=340 (6.60% non-response rate), in urban n= 63 (1.57% non-response), and peri-urban n= 77 (3.75% non-response).
²Defined as household expenditure per capita below poverty line. Poverty line in 2006: for urban areas, MK113.39 (US$ 0.91); rural south MK32.90 (US$0.25). The poverty line for urban areas was used to classify per capita expenditure in Peri-urban areas. Source: [21]http://www.ifpri.org/themes/mp18/malawipms/pmsprofile.pdf. Poverty lines reflated to 2006 using the Rural and Urban (all items) Consumer Price Indices for Malawi (NSO in http://www.nsomalawi.mw/component/content/article/21.html accessed 1 August 2007).

ISSN: 1475-2875